Maimard Yameela, Woradet Somkiattiyos, Chaimay Bhunyabhadh
Department of Disease Control, Institute for Urban Disease Control and Prevention, Ministry of Public Health, Bangkok, Thailand.
Department of Public Health, Faculty of Health and Sport Science, Thaksin University, Phatthalung Campus, Phatthalung, Thailand.
Int J Prev Med. 2023 Feb 18;14:13. doi: 10.4103/ijpvm.ijpvm_104_22. eCollection 2023.
Globally and in Thailand, the incidence of colorectal cancer (CRC) is third-ranked behind lung and breast cancer, respectively. This hospital-based retrospective cohort study aimed to determine factors associated with mortality among patients with CRC.
This study was performed by using the secondary data of the cancer registry among patients with CRC registered in Phatthalung Hospital. Two hundred twenty-eight patients with CRC were diagnosed and followed up from January 2014 to December 2018. Multiple logistic regression analysis was used to analyze factors associated with mortality among subjects with CRC.
The results revealed that the proportion of mortality among subjects with CRC was 50.44% (115 cases) at six months of following up. Subjects who had an increasing age every ten years (adjusted odds ratio [OR] = 1.40, 95 percent confidence interval [95% CI]: 1.09-1.80) were diagnosed with CRC at stage 3 (2.64, 1.19-5.84) and at stage 4 (11.63, 2.69-50.15) more likely to die. Also, subjects who received a combination of chemotherapy and radiotherapy treatment (3.44, 1.20-9.85), combination treatment of surgery, and postoperative care (2.46, 1.22-4.94) were more likely to die. Subjects who had not had surgery treatment were more likely to die (35.00, 7.44-168.27).
In conclusion, factors such as the age of patients, stage of CRC, and treatment were associated with mortality among patients with CRC. Hence, medical and health professionals should consider these factors according to the treatment and optimization in patients with CRC.
在全球范围内以及泰国,结直肠癌(CRC)的发病率分别位居肺癌和乳腺癌之后,位列第三。这项基于医院的回顾性队列研究旨在确定CRC患者死亡的相关因素。
本研究使用了博他伦医院登记的CRC患者的癌症登记二级数据。2014年1月至2018年12月期间,对228例CRC患者进行了诊断和随访。采用多因素logistic回归分析CRC患者死亡的相关因素。
结果显示,随访6个月时,CRC患者的死亡率为50.44%(115例)。年龄每增加10岁(调整优势比[OR]=1.40,95%置信区间[95%CI]:1.09-1.80)、诊断为3期CRC(2.64,1.19-5.84)和4期CRC(11.63,2.69-50.15)的患者死亡可能性更高。此外,接受化疗和放疗联合治疗(3.44,1.20-9.85)、手术及术后护理联合治疗(2.46,1.22-4.94)的患者死亡可能性更高。未接受手术治疗的患者死亡可能性更高(35.00,7.44-168.27)。
总之,患者年龄、CRC分期和治疗等因素与CRC患者的死亡率相关。因此,医疗卫生专业人员应根据CRC患者的治疗情况考虑这些因素并进行优化。